Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE) (vol 37, pg 2687, 2019)

被引：0
|
作者：
Sando, Eiichiro [1 ,2 ,3 ]
Suzuki, Motoi [1 ]
Furumoto, Akitsugu [4 ]
Asoh, Norichika [5 ]
Yaegashi, Makito [3 ]
Aoshima, Masahiro [6 ]
Ishida, Masayuki [7 ]
Hamaguchi, Sugihiro [8 ]
Otsuka, Yoshihito [9 ]
Morimoto, Konosuke [1 ,2 ]
机构：
[1] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Sakamoto 1-12-4, Nagasaki 8528523, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Trop Med, Nagasaki, Japan
[3] Kameda Med Ctr, Dept Gen Internal Med, Chiba, Japan
[4] Nagasaki Rosai Hosp, Dept Infect Dis, Nagasaki, Japan
[5] Juzenkai Hosp, Dept Internal Med, Nagasaki, Japan
[6] Kameda Med Ctr, Dept Pulmonol, Chiba, Japan
[7] Chikamori Hosp, Dept Resp Med, Kochi, Japan
[8] Fukushima Med Univ, Dept Gen Internal Med, Fukushima, Japan
[9] Kameda Med Ctr, Dept Lab Med, Chiba, Japan
来源：
VACCINE | 2020年 / 38卷 / 17期
关键词：
D O I：
10.1016/j.vaccine.2020.03.031
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
下载
收藏
页码：3404 / 3404
页数：1
相关论文
共 50 条
  • [41] Impact of the 13-Valent Pneumococcal Conjugate Vaccine Among Adults: A Systematic Review and Meta-analysis
    Vadlamudi, Nirma Khatri
    Chen, Anna
    Marra, Fawziah
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (01) : 34 - 49
  • [42] Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study
    Andrejko, Kristin L.
    Gierke, Ryan
    Rowlands, Jemma, V
    Rosen, Jennifer B.
    Thomas, Ann
    Landis, Zachary Q.
    Rosales, Maria
    Petit, Sue
    Schaffner, William
    Holtzman, Corinne
    Barnes, Meghan
    Farley, Monica M.
    Harrison, Lee H.
    McGee, Lesley
    Chochua, Sopio
    Verani, Jennifer R.
    Cohen, Adam L.
    Pilishvili, Tamara
    Kobayashi, Miwako
    VACCINE, 2024, 42 (16) : 3555 - 3563
  • [43] Effectiveness of the 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media (vol 73, pg 650, 2022)
    Dagan, Ron
    van der Beek, Bart Adriaan
    Ben-Shimol, Shalom
    Pilishvili, Tamara
    Givon-Lavi, Noga
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (02) : 372 - 372
  • [44] Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-serotype community acquired pneumococcal diseases among children in China: A test-negative case-control study
    Liu, Xiaofei
    Li, Yudan
    Chen, Qinghui
    Shen, Jiaming
    Zheng, Benfeng
    Zhang, Youyi
    Wang, Biying
    You, Lijun
    Zhang, Jun
    Tian, Jianmei
    Luan, Lin
    Shao, Xuejun
    Zhao, Genming
    Zhang, Tao
    VACCINE, 2024, 42 (06) : 1275 - 1282
  • [45] Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study
    McCollum, Eric D.
    Nambiar, Bejoy
    Deula, Rashid
    Zadutsa, Beatiwel
    Bondo, Austin
    King, Carina
    Beard, James
    Liyaya, Harry
    Mankhambo, Limangeni
    Lazzerini, Marzia
    Makwenda, Charles
    Masache, Gibson
    Bar-Zeev, Naor
    Kazembe, Peter N.
    Mwansambo, Charles
    Lufesi, Norman
    Costello, Anthony
    Armstrong, Ben
    Colbourn, Tim
    PLOS ONE, 2017, 12 (01):
  • [46] Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease Among Adults With HIV-United States, 2008-2018
    Kobayashi, Miwako
    Matanock, Almea
    Xing, Wei
    Adih, William K.
    Li, Jianmin
    Gierke, Ryan
    Almendares, Olivia
    Reingold, Arthur
    Alden, Nisha
    Petit, Susan
    Farley, Monica M.
    Harrison, Lee H.
    Holtzman, Corinne
    Baumbach, Joan
    Thomas, Ann
    Schaffner, William
    McGee, Lesley
    Pilishvili, Tamara
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 90 (01) : 6 - 14
  • [47] Evaluation of the impact of 13-valent pneumococcal conjugate vaccine immunization in children by surveillance of culture-confirmed pneumococcal disease: A prospective clinical microbiological study
    Chen, Chih-Ho
    Su, Lin-Hui
    Li, Hsin-Chieh
    Hsu, Mei-Hua
    Wu, Tsu-Lan
    Chen, Chyi-Liang
    Kuo, Kuang-Che
    Hsiao, Chang-Chun
    Chiu, Cheng-Hsun
    VACCINE, 2019, 37 (36) : 5147 - 5152
  • [48] Potential impact of replacing the 13-valent pneumococcal conjugate vaccine with 15-valent or 20-valent pneumococcal conjugate vaccine in the 1+1 infant schedule in England: a modelling study
    Choi, Yoon Hong
    Bertran, Marta
    Litt, David J.
    Ladhani, Shamez N.
    Miller, Elizabeth
    LANCET PUBLIC HEALTH, 2024, 9 (09):
  • [49] Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain (vol 37, pg 1449, 2018)
    Hernandez-Bou, Susanna
    Gomez, Borja
    Mintegi, Santiago
    Garcia-Garcia, Juan J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (08) : 1457 - 1457
  • [50] Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study
    Zhang, Tao
    Zhang, Jun
    Shao, Xuejun
    Feng, Shuang
    Xu, Xinxin
    Zheng, Benfeng
    Liu, Changpeng
    Dai, Zirui
    Jiang, Qin
    Gessner, Bradford D.
    Chen, Qinghui
    Zhu, Jun
    Luan, Lin
    Tian, Jianmei
    Zhao, Genming
    VACCINE, 2021, 39 (33) : 4620 - 4627
12345